Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: David Rimoin, David Altshuler

Premium

David Rimoin, director of the Cedars-Sinai Medical Genetics Institute, has passed away at age 75 from pancreatic cancer.

For 18 years prior to founding the Medical Genetics Institute in 2004, Rimoin served as chair of the Cedars-Sinai Department of Pediatrics. He also previously served as chief of the Division of Medical Genetics at Harbor-UCLA Medical Center and was director of the Genetics Clinic at the Washington University School of Medicine in St. Louis.

From 1979 to 1983, Rimoin served as founding president of the American Board of Medical Genetics. Additionally, he was a member of the Institute of Medicine, a master in the American College of Physicians and an Honorary Life member of Little People of America.

He holds a BS, an MS in genetics, and an MD from McGill University.


David Altshuler has been appointed to the board of directors at Vertex Pharmaceuticals. He is a professor of genetics and medicine at Harvard Medical School, where he has served on the faculty since 2000. He is also a founding member of the Broad Institute and on the faculty of Massachusetts General Hospital in its Department of Molecular Biology, the Diabetes Unit of the Department of Medicine, and in the Center for Human Genetic Research. He holds a BS from the Massachusetts Institute of Technology, a PhD from Harvard University, and an MD from Harvard Medical School.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.